Russell Investments Group, Ltd. Protagonist Therapeutics, Inc Transaction History

Russell Investments Group, Ltd.

$60.3 Billion
Q2 2024

A detailed history of Russell Investments Group, Ltd. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,216 shares of PTGX stock, worth $55,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,216

Previous 1,216 -0.0%

Holding current value

$55,741

Previous $35,000 20.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$21.79 - $32.15 $26,496 - $39,094	1,216 New	1,216 $35,000
Q3 2023 Nov 13, 2023	SELL	$16.68 - $23.66 $725,746 - $1.03 Million	-43,510 Reduced 99.97%	12 $0
Q2 2023 Aug 10, 2023	SELL	$18.02 - $29.36 $1.02 Million - $1.66 Million	-56,564 Reduced 56.52%	43,522 $1.2 Million
Q1 2023 May 09, 2023	SELL	$10.78 - $25.38 $1.07 Million - $2.51 Million	-98,883 Reduced 49.7%	100,086 $2.3 Million
Q4 2022 Feb 08, 2023	SELL	$7.36 - $11.17 $234,622 - $356,077	-31,878 Reduced 13.81%	198,969 $2.17 Million
Q3 2022 Nov 04, 2022	SELL	$7.86 - $11.71 $461,499 - $687,552	-58,715 Reduced 20.28%	230,847 $1.94 Million
Q2 2022 Jul 29, 2022	BUY	$7.06 - $25.52 $751,508 - $2.72 Million	106,446 Added 58.13%	289,562 $2.29 Million
Q1 2022 May 05, 2022	BUY	$23.34 - $36.08 $455,760 - $704,534	19,527 Added 11.94%	183,116 $4.34 Million
Q4 2021 Jan 21, 2022	BUY	$17.63 - $37.1 $1.53 Million - $3.21 Million	86,587 Added 112.45%	163,589 $5.59 Million
Q3 2021 Nov 08, 2021	BUY	$12.95 - $49.69 $297,824 - $1.14 Million	22,998 Added 42.59%	77,002 $1.36 Million
Q2 2021 Aug 04, 2021	BUY	$25.57 - $44.88 $83,639 - $146,802	3,271 Added 6.45%	54,004 $2.42 Million
Q1 2021 May 10, 2021	SELL	$19.02 - $31.15 $82,299 - $134,786	-4,327 Reduced 7.86%	50,733 $1.31 Million
Q4 2020 Feb 08, 2021	SELL	$18.49 - $25.13 $948,389 - $1.29 Million	-51,292 Reduced 48.23%	55,060 $1.11 Million
Q3 2020 Nov 09, 2020	SELL	$15.19 - $22.4 $1.15 Million - $1.69 Million	-75,384 Reduced 41.48%	106,352 $2.08 Million
Q2 2020 Aug 05, 2020	BUY	$6.19 - $18.84 $478,462 - $1.46 Million	77,296 Added 74.01%	181,736 $3.21 Million
Q1 2020 May 06, 2020	BUY	$5.4 - $9.22 $307,108 - $524,359	56,872 Added 119.56%	104,440 $736,000
Q4 2019 Jan 29, 2020	SELL	$4.69 - $13.45 $137,262 - $393,641	-29,267 Reduced 38.09%	47,568 $334,000
Q3 2019 Nov 01, 2019	BUY	$9.41 - $16.56 $723,017 - $1.27 Million	76,835 New	76,835 $926,000
Q4 2018 Feb 11, 2019	SELL	$6.3 - $10.44 $37,170 - $61,596	-5,900 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$6.82 - $11.26 $40,238 - $66,434	5,900 New	5,900 $61,000

Others Institutions Holding PTGX

# of Institutions

212

Shares Held

59.1M

Call Options Held

19K

Put Options Held

107K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Protagonist Therapeutics, Inc Transaction History